A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer
Clinical trial NCT02795988 · COMPLETED
Trial details
- NCT number
- NCT02795988
- Sponsor
- Imugene Limited
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-30
- Primary completion
- 2024-03-20
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.